Explore Research Products in the PAR
It may take a few hours for recently added research products to appear in PAR search results.


Title: A prototype closed-loop brain–machine interface for the study and treatment of pain
Chronic pain is characterized by discrete pain episodes of unpredictable frequency and duration. This hinders the study of pain mechanisms and contributes to the use of pharmacological treatments associated with side effects, addiction and drug tolerance. Here, we show that a closed-loop brain–machine interface (BMI) can modulate sensory-affective experiences in real time in freely behaving rats by coupling neural codes for nociception directly with therapeutic cortical stimulation. The BMI decodes the onset of nociception via a state-space model on the basis of the analysis of online-sorted spikes recorded from the anterior cingulate cortex (which is critical for pain processing) and couples real-time pain detection with optogenetic activation of the prelimbic prefrontal cortex (which exerts top–down nociceptive regulation). In rats, the BMI effectively inhibited sensory and affective behaviours caused by acute mechanical or thermal pain, and by chronic inflammatory or neuropathic pain. The approach provides a blueprint for demand-based neuromodulation to treat sensory-affective disorders, and could be further leveraged for nociceptive control and to study pain mechanisms.  more » « less
Award ID(s):
1835000
PAR ID:
10315568
Author(s) / Creator(s):
; ; ; ; ; ; ; ; ; ; ; ;
Date Published:
Journal Name:
Nature Biomedical Engineering
ISSN:
2157-846X
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. ; ; ; ; ; ; ; (, Science Translational Medicine)
    Pain relief on-demand Chronic pain is a debilitating condition for which there are no effective treatments. The primary somatosensory cortex (S1) and the anterior cingulate cortex (ACC) are involved in decoding pain components, and electrical stimulation of the prefrontal cortex (PFC) has been shown to exert analgesic effects. Here, Sun et al. developed a multiregion brain-machine interface (BMI) able to detect pain from electrical signals in S1 and ACC and provide on-demand PFC stimulation. The BMI was able to accurately detect and treat acute and chronic pain in rats; the analgesic effects were stable over time. The results suggest that BMI approaches might be effective for treating chronic pain of different etiologies. 
    more » « less
  2. ; ; ; ; ; ; ; ; ; ; et al (, Aging Cell)
    Abstract Aging is generally associated with declining somatosensory function, which seems at odds with the high prevalence of chronic pain in older people. This discrepancy is partly related to the high prevalence of degenerative diseases such as osteoarthritis in older people. However, whether aging alters pain processing in the primary somatosensory cortex (S1), and if so, whether it promotes pain chronification is largely unknown. Herein, we report that older mice displayed prolonged nociceptive behavior following nerve injury when compared with mature adult mice. The expression of peroxisome proliferator‐activated receptor‐gamma coactivator‐1α (PGC‐1α) in S1 was decreased in older mice, whereas PGC‐1α haploinsufficiency promoted prolonged nociceptive behavior after nerve injury. Both aging and PGC‐1α haploinsufficiency led to abnormal S1 neural dynamics, revealed by intravital two‐photon calcium imaging. Manipulating S1 neural dynamics affected nociceptive behavior after nerve injury: chemogenetic inhibition of S1 interneurons aggravated nociceptive behavior in naive mice; chemogenetic activation of S1 interneurons alleviated nociceptive behavior in older mice. More interestingly, adeno‐associated virus‐mediated expression of PGC‐1α in S1 interneurons ameliorated aging‐associated chronification of nociceptive behavior as well as aging‐related S1 neural dynamic changes. Taken together, our results showed that aging‐associated decrease of PGC‐1α promotes pain chronification, which might be harnessed to alleviate the burden of chronic pain in older individuals. 
    more » « less
  3. ; (, Frontiers in Synaptic Neuroscience)
    Endocannabinoids are lipid neuromodulators that are synthesized on demand and primarily signal in a retrograde manner to elicit depression of excitatory and inhibitory synapses. Despite the considerable interest in their potential analgesic effects, there is evidence that endocannabinoids can have both pro-nociceptive and anti-nociceptive effects. The mechanisms contributing to the opposing effects of endocannabinoids in nociception need to be better understood before cannabinoid-based therapies can be effectively utilized to treat pain. Using the medicinal leech, Hirudo verbana , this work investigates whether endocannabinoids modulate tonic inhibition onto non-nociceptive afferents. In voltage clamp recordings, we analyzed changes in the tonic inhibition in pressure-sensitive (P) cells following pre-treatment with endocannabinoids, 2-arachidonoylglycerol (2-AG) or anandamide (AEA). We also tested whether high frequency stimulation (HFS) of nociceptive (N) cells could also modulate tonic inhibition. Both endocannabinoid application and N cell HFS depressed tonic inhibition in the P cell. Depression of tonic inhibition by N cell HFS was blocked by SB 366791 (a TRPV1 inhibitor). SB 366791 also prevented 2-AG-and AEA-induced depression of tonic inhibition. HFS-induced depression was not blocked by tetrahydrolipstatin (THL), which prevents 2-AG synthesis, nor AM 251 (a CB1 receptor inverse agonist). These results illustrate a novel activity-dependent modulation of tonic GABA currents that is mediated by endocannabinoid signaling and is likely to play an important role in sensitization of non-nociceptive afferent pathways. 
    more » « less
  4. (, ENeuro)
    There is considerable interest in cannabinoid-based therapies to treat pain, but activation of the endogenous cannabinoid (endocannabinoid) system can elicit pro- and anti-nociceptive effects. This study tests the hypothesis that the concentration of the endocannabinoid arachidonoylethanolamine (AEA) contributes to whether pro- or anti-nociceptive effects are observed. Experiments were carried out using isolated ganglia from the medicinal leechHirudo verbanawhere it is possible to selectively record from nociceptive and non-nociceptive synapses in the central nervous system (CNS). Previous studies usingHirudohave shown that endocannabinoids depress nociceptive (N) synapses and potentiate of non-nociceptive pressure (P) synapses. In this study, exogenously applied AEA produced depression of N synapses and potentiation of P synapses across the same range of concentrations. However, the results differed when using URB597, a drug that raises AEA by inhibiting fatty acid amine hydrolase (FAAH), the enzyme that metabolizes AEA. Potentiation of P synapses required higher concentrations of URB597 compared to the concentrations needed to elicit depression of N synapses. Interestingly, pairing somatosensory afferent activity with a normally subthreshold concentration of URB597 did elicit potentiation in P synapses. Sensitivity of the nociceptive and non-nociceptive synapses to cannabinoid receptor inhibitors differed when AEA vs. UBR597 was applied. This study demonstrates the complexity of AEA-mediated effects on distinct synapse types that may be informative about the basic biology of endocannabinoid modulation of nociception. Significance StatementWhile there is considerable interest in developing cannabinoid-based analgesics, activation of the endocannabinoid system can produce pro- and anti-nociceptive effects. Which is produced may be due to the endocannabinoid concentration. This concentration hypothesis was examined by assessing the effects of arachidonoylethanolamine (AEA) on identifiable nociceptive and non-nociceptive synapses inHirudo verbana(the medicinal leech). Both types of synapses were equally sensitive to exogenously applied AEA, but when endogenous AEA levels were increased using inhibitors of AEA metabolism, nociceptive synapses were much more sensitive compared to non-nociceptive synapses. These findings may inform why past cannabinoid-based therapies have failed as analgesics and how to develop effective analgesic therapies in the future. 
    more » « less
  5. ; ; ; ; ; ; ; ; ; ; et al (, National congress of bioengineering Proceedings)
    Chronic pain is a major cause of disability worldwide. While acute pain may serve as a protective function, chronic pain and the associated changes in neural processing negatively impact function and quality of life. This neural plasticity may include changes to the autonomic nervous system (ANS) potentially detectable as changes in various physiological signals. Our aim is to evaluate differences in the physiological signals reflecting ANS changes, by comparing healthy subjects and patients with chronic low back pain during standardized pain stimuli. We extracted several features from photoplethysmography (PPG), electrodermal activity (EDA), and respiration, both at rest and during a repeated pinprick test. We found significant group differences in some PPG parameters at rest and in response to the repeated pinprick test. Chronic pain patients had consistently higher basal sympathetic activity, as well as a blunted autonomic response when subjected to nociceptive stimuli. 
    more » « less
  • Citation Formats
  • MLA
  • APA
  • Chicago
  • BibTeX
  • Text Encoded Conversion
  • XML
  • Save / Share this Record
  • Send to Email